| Designer drugs: mechanism of action and adverse effects D Luethi, ME Liechti Archives of Toxicology, 1-49, 2020 | 209 | 2020 |
| Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2, 5-dimethoxy-substituted phenethylamines (2C drugs) A Rickli, D Luethi, J Reinisch, D Buchy, MC Hoener, ME Liechti Neuropharmacology 99, 546-553, 2015 | 193 | 2015 |
| Pharmacological profile of mephedrone analogs and related new psychoactive substances D Luethi, KE Kolaczynska, L Docci, S Krähenbühl, MC Hoener, ME Liechti Neuropharmacology 134, 4-12, 2018 | 109 | 2018 |
| Monoamine transporter and receptor interaction profiles in vitro predict reported human doses of novel psychoactive stimulants and psychedelics D Luethi, ME Liechti International Journal of Neuropsychopharmacology 21 (10), 926-931, 2018 | 67 | 2018 |
| Pharmacological profile of methylphenidate-based designer drugs D Luethi, PJ Kaeser, SD Brandt, S Krähenbühl, MC Hoener, ME Liechti Neuropharmacology 134, 133-140, 2018 | 54 | 2018 |
| Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use D Luethi, MC Hoener, S Krähenbühl, ME Liechti, U Duthaler Biochemical Pharmacology 164, 129-138, 2019 | 50 | 2019 |
| Mechanisms of hepatocellular toxicity associated with new psychoactive synthetic cathinones D Luethi, ME Liechti, S Krähenbühl Toxicology 387, 57-66, 2017 | 50 | 2017 |
| Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs) D Luethi, D Trachsel, MC Hoener, ME Liechti Neuropharmacology 134, 141-148, 2018 | 39 | 2018 |
| Effects of the new psychoactive substances diclofensine, diphenidine, and methoxphenidine on monoaminergic systems D Luethi, MC Hoener, ME Liechti European Journal of Pharmacology 819, 242-247, 2018 | 39 | 2018 |
| Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics D Rudin, ME Liechti, D Luethi Experimental Neurology 343, 113778, 2021 | 36 | 2021 |
| Structural basis of organic cation transporter-3 inhibition B Khanppnavar, J Maier, F Herborg, R Gradisch, E Lazzarin, D Luethi, ... Nature communications 13 (1), 6714, 2022 | 33 | 2022 |
| Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems D Luethi, KE Kolaczynska, M Walter, M Suzuki, KC Rice, BE Blough, ... Journal of Psychopharmacology 33 (7), 831-841, 2019 | 29 | 2019 |
| Liquid chromatography–tandem mass spectrometric assay for the multikinase inhibitor regorafenib in plasma D Luethi, S Durmus, AH Schinkel, JHM Schellens, JH Beijnen, ... Biomedical Chromatography 28 (10), 1366-1370, 2014 | 29 | 2014 |
| Para-halogenation affects monoamine transporter inhibition properties and hepatocellular toxicity of amphetamines and methcathinones D Luethi, M Walter, X Zhou, D Rudin, S Krähenbühl, ME Liechti Frontiers in Pharmacology 10, 438, 2019 | 27 | 2019 |
| Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants SB Vogt, L Ley, L Erne, I Straumann, AM Becker, A Klaiber, F Holze, ... Translational Psychiatry 13 (1), 172, 2023 | 25 | 2023 |
| SLC6 transporter oligomerization K Jayaraman, AK Das, D Luethi, D Szöllősi, GJ Schütz, MEA Reith, ... Journal of Neurochemistry, 2020 | 25 | 2020 |
| Molecular toxicological mechanisms of synthetic cathinones on C2C12 myoblasts X Zhou, D Luethi, GM Sanvee, J Bouitbir, ME Liechti, S Krähenbühl International Journal of Molecular Sciences 20 (7), 1561, 2019 | 24 | 2019 |
| Dopamine transporter trafficking and Rit2 GTPase: Mechanism of action and in vivo impact RR Fagan, PJ Kearney, CG Sweeney, D Luethi, FES Uiterkamp, ... Journal of Biological Chemistry 295 (16), 5229-5244, 2020 | 23 | 2020 |
| Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants L Ley, F Holze, D Arikci, AM Becker, I Straumann, A Klaiber, F Coviello, ... Neuropsychopharmacology 48 (11), 1659-1667, 2023 | 21 | 2023 |
| Receptor interaction profiles of 4-alkoxy-substituted 2, 5-dimethoxyphenethylamines and related amphetamines KE Kolaczynska, D Luethi, D Trachsel, MC Hoener, ME Liechti Frontiers in Pharmacology 10, 1423, 2019 | 21 | 2019 |
Matthias LiechtiUniversity Hospital BaselEmail confirmado em usb.ch
